Earnings Call
Apr 23, 2026
Q1 FY2026
EPS Estimate
5.25
EPS Actual
5.44
Post-Earnings Close
$466.70
Earnings Reaction
-9.2%
Thermo Fisher Scientific opened 2026 with revenue of $11.01 billion, up 6% year-over-year, and adjusted EPS of $5.44, also up 6%, both comfortably ahead of consensus and the company's own internal targets. The $0.14 EPS beat versus prior guidance was split between $0.01 from the newly closed Clario acquisition and $0.13 from operational outperformance, a meaningful signal of execution quality given the macro complexity management acknowledged throughout the call. Adjusted operating margin came in at 21.8%, down just 10 basis points year-over-year despite absorbing approximately 80 basis points of headwind from tariffs and related foreign exchange, a testament to the productivity gains delivered through the PPI Business System.
Report generated on Apr 23, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full TMO analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.